Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve C Bain

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Safety|May 20, 2020
Safety of injectable semaglutide for type 2 diabetesRajesh Peter, Steve C Bain
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 19, 2020
The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Renal Outcomes in Type 2 DiabetesWin L Yin, Steve C Bain, Thinzar Min
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 2, 2014
Insulin degludec versus insulin glargine in type 1 and type 2 diabetes mellitus: a meta-analysis of endpoints in phase 3a trialsJiten Vora, Torsten Christensen, Azhar Rana, et al.
The British Journal of Cardiology|June 24, 2024
Assessing opinion on lower LDL-cholesterol lowering, and the role of newer lipid-reducing treatment optionsDerek L Connolly, Azfar Zaman, Nigel E Capps, et al.
Metabolism: Clinical and Experimental|March 2, 2010
Adiponectin, total antioxidant status, and urine albumin excretion in the low-risk "Golden Years" type 1 diabetes mellitus cohortSarah Lyn Prior, Ting Seng Tang, Geoff V Gill, et al.
Diabetes Research and Clinical Practice|January 7, 2011
Association of the adiponectin rs266729 C>G variant and coronary heart disease in the low risk 'Golden Years' type 1 diabetes cohortSarah L Prior, Danielle A Jones, Geoffrey V Gill, et al.
Frontiers in Endocrinology|August 21, 2019
Resistance Isn't Futile: The Physiological Basis of the Health Effects of Resistance Exercise in Individuals With Type 1 DiabetesOlivia McCarthy, Othmar Moser, Max L Eckstein, et al.
Disease Markers|June 12, 2012
Association of the PGC-1α rs8192678 variant with microalbuminuria in subjects with type 2 diabetes mellitusSarah L Prior, Amy R Clark, Danielle A Jones, et al.
Diabetes Care|November 6, 2016
Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal TrialJort Kropff, Pratik Choudhary, Sankalpa Neupane, et al.
Clinical Science (London, England : 1979)|May 30, 2003
Association between the cholesteryl ester transfer protein TaqI-detectable B polymorphism and low high-density lipoprotein cholesterol concentration in SaudisNassr M Al-Daghri, Omer Al-Attas, Ashok Patel, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Safety|May 20, 2020
Safety of injectable semaglutide for type 2 diabetesRajesh Peter, Steve C Bain
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 19, 2020
The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Renal Outcomes in Type 2 DiabetesWin L Yin, Steve C Bain, Thinzar Min
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 2, 2014
Insulin degludec versus insulin glargine in type 1 and type 2 diabetes mellitus: a meta-analysis of endpoints in phase 3a trialsJiten Vora, Torsten Christensen, Azhar Rana, et al.
The British Journal of Cardiology|June 24, 2024
Assessing opinion on lower LDL-cholesterol lowering, and the role of newer lipid-reducing treatment optionsDerek L Connolly, Azfar Zaman, Nigel E Capps, et al.
Metabolism: Clinical and Experimental|March 2, 2010
Adiponectin, total antioxidant status, and urine albumin excretion in the low-risk "Golden Years" type 1 diabetes mellitus cohortSarah Lyn Prior, Ting Seng Tang, Geoff V Gill, et al.
Diabetes Research and Clinical Practice|January 7, 2011
Association of the adiponectin rs266729 C>G variant and coronary heart disease in the low risk 'Golden Years' type 1 diabetes cohortSarah L Prior, Danielle A Jones, Geoffrey V Gill, et al.
Frontiers in Endocrinology|August 21, 2019
Resistance Isn't Futile: The Physiological Basis of the Health Effects of Resistance Exercise in Individuals With Type 1 DiabetesOlivia McCarthy, Othmar Moser, Max L Eckstein, et al.
Disease Markers|June 12, 2012
Association of the PGC-1α rs8192678 variant with microalbuminuria in subjects with type 2 diabetes mellitusSarah L Prior, Amy R Clark, Danielle A Jones, et al.
Diabetes Care|November 6, 2016
Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal TrialJort Kropff, Pratik Choudhary, Sankalpa Neupane, et al.
Clinical Science (London, England : 1979)|May 30, 2003
Association between the cholesteryl ester transfer protein TaqI-detectable B polymorphism and low high-density lipoprotein cholesterol concentration in SaudisNassr M Al-Daghri, Omer Al-Attas, Ashok Patel, et al.
Pageof 1